Study of Safety and Tolerability of Intravenous CRS-100 in Adults With Carcinoma and Liver Metastases

NCT00327652 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

9

Enrollment

INDUSTRY

Sponsor class

Conditions

Neoplasm Metastasis
Liver Neoplasms
Carcinoma

Interventions

DRUG: CRS-100

Sponsor

Anza Therapeutics, Inc.